Abstract

Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers

Author(s): Desai Hiral D, Shirley Kara L, Penzak Scott R, Strom J Grady, Hon Yeun Yi, Spratlin Vicky, Jann Michael W

Issue: Nov/Dec 2003 - Compounding for Investigational Studies

Page(s): 481-484

Download in electronic PDF format for $75
  • Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Page 1
  • Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Page 2
  • Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Page 3
  • Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Page 4

Abstract

The pharmacokinetics of an extemporaneous 25-mg suppository formulation of sumatriptan were compared to those of the marketed 25-mg oral tablet. Sixteen healthy volunteers enrolled in this open-label, two-way crossover study. Fifteen subjects completed the study. The pharmacokinetics of the suppository and the oral tablet were significantly different. Tmax was observed at 0.5 hours in 12 of 15 subjects with the extemporaneous suppository, compared with the range of 0.75 hours to 1.5 hours in 13 of 15 subjects with the oral tablet. The mean Cmax and area under the plasma concentration time curve were 5.4-fold and fourfold greater for the suppository than for the oral tablet. Both formulations were well tolerated, with mild headache experienced in only three subjects. Based upon its pharmacokinetic profile, the extemporaneous suppository may represent a useful alternative therapeutic administration route for some patients.

Related Keywords

  • Sumatriptan, pharmacokinetics of

Related Categories

  • PAIN MANAGEMENT
  • PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2003
Pg. 481-484
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers
Author(s): Desai Hiral D, Shirley Kara L, Penzak Scott R, Strom J Grady, Hon Yeun Yi, Spratlin Vicky, Jann Michael W
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2004
Pg. 221
Sumatriptan 25-mg Suppository
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 147
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 220
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 301
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2007
Pg. 329
Ketoconazole 25-mg Liquid Suppository
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 380
Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 1998
Pg. 158
Sumatriptan 5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 145
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 321
Neomycin Sulfate 25-mg/mL Oral Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 320
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Author(s): Allen Loyd V Jr
Jan/Feb 2002
Pg. 16-18
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Author(s): Vail Jane
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2025
Pg. 43-44
Chloral Hydrate 25-mg/mL Oral Suspension
Author(s):
Mar/Apr 1997
Pg. 101
Acetazolamide 25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 184
Spironolactone 25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 135
Griseofulvin 25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 480
Ursodiol 25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr